dapagliflozin/metformin hydrochloride

Details

Files
Generic Name:
dapagliflozin/metformin hydrochloride
Project Status:
Complete
Therapeutic Area:
Diabetes Mellitus, Type 2
Manufacturer:
AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
XigDuo
Project Line:
Reimbursement Review
Project Number:
SR0468-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Diabetes Mellitus, Type 2
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: